Long-term outcomes of the total or supracervical hysterectomy trial

W. Jerod Greer, Holly E. Richter, Thomas L. Wheeler, R. Edward Varner, Jeff M. Szychowski, Miriam Kuppermann, Lee A. Learman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Participants in the multicenter, randomized Total or Supracervical Hysterectomy (TOSH) trial showed within-group improvement in pelvic floor symptoms 2 years postsurgery and no differences between supracervical (SCH) versus total hysterectomy (TAH). This study describes longer term outcomes from the largest recruiting site. Methods: Questionnaires addressing pelvic symptoms, sexual function, and health-related quality of life (HRQOL) were administered. Linear models and McNemar test were used. Results: Thirty-seven participants (69%) responded (19 TAH, 18 SCH); mean follow up was 9.1 ± 0.7 years. No between-group differences emerged in urinary incontinence, voiding dysfunction, pelvic prolapse symptoms, and overall HRQOL. Within-group analysis showed significant improvement in the ability to have and enjoy sex (P = 0.002) and SF-36 physical component summary scores (P = 0.03) among women randomized to TAH. Conclusions: Nine years after surgery, TOSH participants maintained improvements in and show no major between-group differences in lower urinary tract or pelvic floor symptoms.

Original languageEnglish (US)
Pages (from-to)49-57
Number of pages9
JournalFemale Pelvic Medicine and Reconstructive Surgery
Volume16
Issue number1
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Hysterectomy
Pelvic Floor
Quality of Life
Prolapse
Reproductive Health
Urinary Incontinence
Urinary Tract
Linear Models

Keywords

  • Health-related quality of life
  • Prolapse symptoms
  • Sexual function
  • Supracervical hysterectomy
  • Total abdominal hysterectomy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Surgery
  • Urology

Cite this

Greer, W. J., Richter, H. E., Wheeler, T. L., Varner, R. E., Szychowski, J. M., Kuppermann, M., & Learman, L. A. (2010). Long-term outcomes of the total or supracervical hysterectomy trial. Female Pelvic Medicine and Reconstructive Surgery, 16(1), 49-57. https://doi.org/10.1097/SPV.0b013e3181cec343

Long-term outcomes of the total or supracervical hysterectomy trial. / Greer, W. Jerod; Richter, Holly E.; Wheeler, Thomas L.; Varner, R. Edward; Szychowski, Jeff M.; Kuppermann, Miriam; Learman, Lee A.

In: Female Pelvic Medicine and Reconstructive Surgery, Vol. 16, No. 1, 2010, p. 49-57.

Research output: Contribution to journalArticle

Greer, WJ, Richter, HE, Wheeler, TL, Varner, RE, Szychowski, JM, Kuppermann, M & Learman, LA 2010, 'Long-term outcomes of the total or supracervical hysterectomy trial', Female Pelvic Medicine and Reconstructive Surgery, vol. 16, no. 1, pp. 49-57. https://doi.org/10.1097/SPV.0b013e3181cec343
Greer, W. Jerod ; Richter, Holly E. ; Wheeler, Thomas L. ; Varner, R. Edward ; Szychowski, Jeff M. ; Kuppermann, Miriam ; Learman, Lee A. / Long-term outcomes of the total or supracervical hysterectomy trial. In: Female Pelvic Medicine and Reconstructive Surgery. 2010 ; Vol. 16, No. 1. pp. 49-57.
@article{af3da186d8dc40ffb7394ac6f416da94,
title = "Long-term outcomes of the total or supracervical hysterectomy trial",
abstract = "Objective: Participants in the multicenter, randomized Total or Supracervical Hysterectomy (TOSH) trial showed within-group improvement in pelvic floor symptoms 2 years postsurgery and no differences between supracervical (SCH) versus total hysterectomy (TAH). This study describes longer term outcomes from the largest recruiting site. Methods: Questionnaires addressing pelvic symptoms, sexual function, and health-related quality of life (HRQOL) were administered. Linear models and McNemar test were used. Results: Thirty-seven participants (69{\%}) responded (19 TAH, 18 SCH); mean follow up was 9.1 ± 0.7 years. No between-group differences emerged in urinary incontinence, voiding dysfunction, pelvic prolapse symptoms, and overall HRQOL. Within-group analysis showed significant improvement in the ability to have and enjoy sex (P = 0.002) and SF-36 physical component summary scores (P = 0.03) among women randomized to TAH. Conclusions: Nine years after surgery, TOSH participants maintained improvements in and show no major between-group differences in lower urinary tract or pelvic floor symptoms.",
keywords = "Health-related quality of life, Prolapse symptoms, Sexual function, Supracervical hysterectomy, Total abdominal hysterectomy",
author = "Greer, {W. Jerod} and Richter, {Holly E.} and Wheeler, {Thomas L.} and Varner, {R. Edward} and Szychowski, {Jeff M.} and Miriam Kuppermann and Learman, {Lee A.}",
year = "2010",
doi = "10.1097/SPV.0b013e3181cec343",
language = "English (US)",
volume = "16",
pages = "49--57",
journal = "Female Pelvic Medicine and Reconstructive Surgery",
issn = "2151-8378",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Long-term outcomes of the total or supracervical hysterectomy trial

AU - Greer, W. Jerod

AU - Richter, Holly E.

AU - Wheeler, Thomas L.

AU - Varner, R. Edward

AU - Szychowski, Jeff M.

AU - Kuppermann, Miriam

AU - Learman, Lee A.

PY - 2010

Y1 - 2010

N2 - Objective: Participants in the multicenter, randomized Total or Supracervical Hysterectomy (TOSH) trial showed within-group improvement in pelvic floor symptoms 2 years postsurgery and no differences between supracervical (SCH) versus total hysterectomy (TAH). This study describes longer term outcomes from the largest recruiting site. Methods: Questionnaires addressing pelvic symptoms, sexual function, and health-related quality of life (HRQOL) were administered. Linear models and McNemar test were used. Results: Thirty-seven participants (69%) responded (19 TAH, 18 SCH); mean follow up was 9.1 ± 0.7 years. No between-group differences emerged in urinary incontinence, voiding dysfunction, pelvic prolapse symptoms, and overall HRQOL. Within-group analysis showed significant improvement in the ability to have and enjoy sex (P = 0.002) and SF-36 physical component summary scores (P = 0.03) among women randomized to TAH. Conclusions: Nine years after surgery, TOSH participants maintained improvements in and show no major between-group differences in lower urinary tract or pelvic floor symptoms.

AB - Objective: Participants in the multicenter, randomized Total or Supracervical Hysterectomy (TOSH) trial showed within-group improvement in pelvic floor symptoms 2 years postsurgery and no differences between supracervical (SCH) versus total hysterectomy (TAH). This study describes longer term outcomes from the largest recruiting site. Methods: Questionnaires addressing pelvic symptoms, sexual function, and health-related quality of life (HRQOL) were administered. Linear models and McNemar test were used. Results: Thirty-seven participants (69%) responded (19 TAH, 18 SCH); mean follow up was 9.1 ± 0.7 years. No between-group differences emerged in urinary incontinence, voiding dysfunction, pelvic prolapse symptoms, and overall HRQOL. Within-group analysis showed significant improvement in the ability to have and enjoy sex (P = 0.002) and SF-36 physical component summary scores (P = 0.03) among women randomized to TAH. Conclusions: Nine years after surgery, TOSH participants maintained improvements in and show no major between-group differences in lower urinary tract or pelvic floor symptoms.

KW - Health-related quality of life

KW - Prolapse symptoms

KW - Sexual function

KW - Supracervical hysterectomy

KW - Total abdominal hysterectomy

UR - http://www.scopus.com/inward/record.url?scp=80053096505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053096505&partnerID=8YFLogxK

U2 - 10.1097/SPV.0b013e3181cec343

DO - 10.1097/SPV.0b013e3181cec343

M3 - Article

AN - SCOPUS:80053096505

VL - 16

SP - 49

EP - 57

JO - Female Pelvic Medicine and Reconstructive Surgery

JF - Female Pelvic Medicine and Reconstructive Surgery

SN - 2151-8378

IS - 1

ER -